Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qvar Autohaler vs conventional fixed-combination therapy in children with stable asthma
2004-001928-20Phase 4Completed
- Sponsor
- UCB
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of beclomethasone in asthma (2 arms), sponsored by UCB. Primary endpoints: Effectiveness comparison of Qvar Autohaler vs conventional fixed-combination therapy and Safety of Qvar Autohaler. Started Aug 2005; status: completed.
02
Drugs
beclomethasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2004-001928-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001928-20.